AZD4573
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD4573, covering 2024-08-28 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer [Phase 1, Phase 2]